nach oben

Neuropsychology Review

Erschienen in:

01.09.2007

Neuropsychological Consequences of Opiate Use

verfasst von: Staci A. Gruber, Marisa M. Silveri, Deborah A. Yurgelun-Todd

Erschienen in: Neuropsychology Review | Ausgabe 3/2007

Einloggen, um Zugang zu erhalten

Abstract

Approximately 3.7 million individuals have used heroin and other opiate substances in their lifetime. Despite increasing knowledge of the effects of heroin, it remains the most abused opiate and use among adults has recently increased. The empirical literature examining the neurocognitive effects of acute and chronic opioid use remains limited; however, findings to date suggest that the use of opiates has both acute and long-term effects on cognitive performance. Neuropsychological data indicate deficits in attention, concentration, recall, visuospatial skills and psychomotor speed with both acute and chronic opioid use. The long-term effects of opiate use appear to have the greatest impact on executive functions, including the ability to shift cognitive set and inhibit inappropriate response tendencies. Factors that contribute to addiction and recovery are also discussed, as it is difficult to disentangle the effects of opiate use on cognitive performance from other factors that may affect neurobehavioral measures.

Amass, L., Nardin, R., Mendelson, J. H., Teoh, S. K., & Woods, B. T. (1992). Quantitative magnetic resonance imaging in heroin- and cocaine-dependent men: a preliminary study. Psychiatry Research, 45(1), 15–23.PubMedCrossRef

American Psychiatric Association, C. o. N. a. S. (1994). Diagnostic and statistical manual of mental disorders (4th ed). Washington DC: American Psychiatric Association.

Appel, P. W., & Gordon, N. B. (1976). Digit-symbol performance in methadone-treated ex-heroin addicts. American Journal of Psychiatry, 133(11), 1337–1340.PubMed

Bickel, W. K., Odum, A. L., & Madden, G. J. (1999). Impulsivity and cigarette smoking: Delay discounting in current, never, and ex-smokers. Psychopharmacology (Berl), 146(4), 447–454.CrossRef

Brooner, R. K., King, V. L., Kidorf, M., Schmidt, C. W., Jr., & Bigelow, G. E. (1997). Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. Archives of General Psychiatry, 54(1), 71–80.PubMed

Bruhn, P., & Maage, N. (1975). Intellectual and neuropsychological functions in young men with heavy and long-term patterns of drug abuse. American Journal of Psychiatry, 132(4), 397–401.PubMed

Carlin, A. S. (1986). Neuropsychological consequences of drug abuse. In I. Grant & K. M. Adams (Eds.), Neuropsychological assessment of neuropsychiatric disorders (pp. 486–503). New York: Oxford University Press.

Christensen, O., Christensen, P., Sonnenschein, C., Nielsen, P. R., & Jacobsen, S. (1996). Analgesic effect of intraarticular morphine. A controlled, randomised and double-blind study. Acta Anaesthesiologica Scandinavica, 40(7), 842–846.PubMed

Cleeland, C. S., Nakamura, Y., Howland, E. W., Morgan, N. R., Edwards, K. R., & Backonja, M. (1996). Effects of oral morphine on cold pressor tolerance time and neuropsychological performance. Neuropsychopharmacology, 15(3), 252–262.PubMedCrossRef

Correia, C. J., Walsh, S. L., Bigelow, G. E., & Strain, E. C. (2006). Effects associated with double-blind omission of buprenorphine/naloxone over a 98-h period. Psychopharmacology (Berl), 189(3), 297–306.CrossRef

Cruz, S. L., Villarreal, J. E., & Volkow, N. D. (1996). Further evidence that naloxone acts as an inverse opiate agonist: Implications for drug dependence and withdrawal. Life Science, 58(26), PL381–PL389.CrossRef

Curran, H. V., Kleckham, J., Bearn, J., Strang, J., & Wanigaratne, S. (2001). Effects of methadone on cognition, mood and craving in detoxifying opiate addicts: A dose-response study. Psychopharmacology (Berl), 154(2), 153–160.CrossRef

Daglish, M. R., Weinstein, A., Malizia, A. L., Wilson, S., Melichar, J. K., Lingford-Hughes, A., et al. (2003). Functional connectivity analysis of the neural circuits of opiate craving: “More” rather than “different”? Neuroimage, 20(4), 1964–1970.PubMedCrossRef

Danos, P., Van Roos, D., Kasper, S., Bromel, T., Broich, K., Krappel, C., et al. (1998). Enlarged cerebrospinal fluid spaces in opiate-dependent male patients: A stereological CT study. Neuropsychobiology, 38(2), 80–83.PubMedCrossRef

Darke, S., Sims, J., McDonald, S., & Wickes, W. (2000). Cognitive impairment among methadone maintenance patients. Addiction, 95(5), 687–695.PubMedCrossRef

Davis, P. E., Liddiard, H., & McMillan, T. M. (2002). Neuropsychological deficits and opiate abuse. Drug and Alcohol Dependence, 67(1), 105–108.PubMedCrossRef

Dole, V. P., & Nyswander, M. (1965). A medical treatment for diacetylmorphine (heroin) addiction. A clinical trial with methadone hydrochloride. Journal of the American Medical Association, 193, 646–650.PubMed

Ersche, K. D., Clark, L., London, M., Robbins, T. W., & Sahakian, B. J. (2006). Profile of executive and memory function associated with amphetamine and opiate dependence. Neuropsychopharmacology, 31(5), 1036–1047.PubMedCrossRef

Forman, S. D., Dougherty, G. G., Casey, B. J., Siegle, G. J., Braver, T. S., Barch, D. M., et al. (2004). Opiate addicts lack error-dependent activation of rostral anterior cingulate. Biological Psychiatry, 55(5), 531–537.PubMedCrossRef

Franceschini, D., Lipartiti, M., & Giusti, P. (1999). Effect of acute and chronic tramadol on [3H]-norepinephrine-uptake in rat cortical synaptosomes. Progress in Neuro-psychopharmacology & Biological Psychiatry, 23(3), 485–496.CrossRef

Gaertner, J., Radbruch, L., Giesecke, T., Gerbershagen, H., Petzke, F., Ostgathe, C., et al. (2006). Assessing cognition and psychomotor function under long-term treatment with controlled release oxycodone in non-cancer pain patients. Acta anaesthesiologica Scandinavica, 50(6), 664–672.PubMedCrossRef

Galynker, I. I., Watras-Ganz, S., Miner, C., Rosenthal, R. N., Des Jarlais, D. C., Richman, B. L., et al. (2000). Cerebral metabolism in opiate-dependent subjects: Effects of methadone maintenance. Mount Sinai Journal of Medicine, 67(5–6), 381–387.PubMed

Gobbi, M., & Mennini, T. (1999). Release studies with rat brain cortical synaptosomes indicate that tramadol is a 5-hydroxytryptamine uptake blocker and not a 5-hydroxytryptamine releaser. European Journal of Pharmacology, 370(1), 23–26.PubMedCrossRef

Gross, A., Jacobs, E. A., Petry, N. M., Badger, G. J., & Bickel, W. K. (2001). Limits to buprenorphine dosing: A comparison between quintuple and sextuple the maintenance dose every 5 days. Drug and Alcohol Dependence, 64(1), 111–116.PubMedCrossRef

Gruber, S. A., Tzilos, G. K., Silveri, M. M., Pollack, M., Renshaw, P. F., Kaufman, M. J., et al. (2006). Methadone maintenance improves cognitive performance after two months of treatment. Experimental and Clinical Psychopharmacology, 14(2), 157–164.PubMedCrossRef

Guerra, D., Sole, A., Cami, J., & Tobena, A. (1987). Neuropsychological performance in opiate addicts after rapid detoxification. Drug and Alcohol Dependence, 20(3), 261–270.PubMedCrossRef

Guo, M., Xu, N. J., Li, Y. T., Yang, J. Y., Wu, C. F., & Pei, G. (2005). Morphine modulates glutamate release in the hippocampal CA1 area in mice. Neuroscience Letters, 381(1–2), 12–15.PubMedCrossRef

Hanks, G. W., O’Neill, W. M., Simpson, P., & Wesnes, K. (1995). The cognitive and psychomotor effects of opioid analgesics. II. A randomized controlled trial of single doses of morphine, lorazepam and placebo in healthy subjects. European Journal of Clinical Pharmacology, 48(6), 455–460.PubMedCrossRef

Joseph, H., Stancliff, S., & Langrod, J. (2000). Methadone maintenance treatment (MMT): A review of historical and clinical issues. Mount Sinai Journal of Medicine, 67(5–6), 347–364.PubMed

Kalivas, P. W., & Volkow, N. D. (2005). The neural basis of addiction: A pathology of motivation and choice. American Journal of Psychiatry, 162(8), 1403–1413.PubMedCrossRef

Kaufman, M. J., Pollack, M. H., Villafuerte, R. A., Kukes, T. J., Rose, S. L., Mendelson, J. H., et al. (1999). Cerebral phosphorus metabolite abnormalities in opiate-dependent polydrug abusers in methadone maintenance. Psychiatry Research, 90(3), 143–152.PubMedCrossRef

Kerr, B., Hill, H., Coda, B., Calogero, M., Chapman, C. R., Hunt, E., et al. (1991). Concentration-related effects of morphine on cognition and motor control in human subjects. Neuropsychopharmacology, 5(3), 157–166.PubMed

Koob, G. F. (1987). Neural substrates of opioid tolerance and dependence. NIDA Research Monograph, 76, 46–52.PubMed

Koob, G. F. (2003). Neuroadaptive mechanisms of addiction: studies on the extended amygdala. European Neuropsychopharmacology, 13(6), 442–452.PubMedCrossRef

Koob, G. F., Ahmed, S. H., Boutrel, B., Chen, S. A., Kenny, P. J., Markou, A., et al. (2004). Neurobiological mechanisms in the transition from drug use to drug dependence. Neuroscience and Biobehavioral Reviews, 27(8), 739–749.PubMedCrossRef

Koob, G. F., & Le Moal, M. (2001). Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology, 24(2), 97–129.PubMedCrossRef

Koob, G. F., Stinus, L., Le Moal, M., & Bloom, F. E. (1989). Opponent process theory of motivation: Neurobiological evidence from studies of opiate dependence. Neuroscience and Biobehavioral Reviews, 13(2–3), 135–140.PubMedCrossRef

Kosten, T. R., Schottenfeld, R., Ziedonis, D., & Falcioni, J. (1993). Buprenorphine versus methadone maintenance for opioid dependence. Journal of Nervous and Mental Disease, 181(6), 358–364.PubMedCrossRef

Kreek, M. J. (1997). Opiate and cocaine addictions: Challenge for pharmacotherapies. Pharmacology, Biochemistry and Behavior, 57(3), 551–569.CrossRef

Krystal, J. H., Woods, S. W., Kosten, T. R., Rosen, M. I., Seibyl, J. P., van Dyck, C. C., et al. (1995). Opiate dependence and withdrawal: Preliminary assessment using single photon emission computerized tomography (SPECT). American Journal of Drug and Alcohol Abuse, 21(1), 47–63.PubMed

Lalovic, B., Kharasch, E., Hoffer, C., Risler, L., Liu-Chen, L. Y., & Shen, D. D. (2006). Pharmacokinetics and pharmacodynamics of oral oxycodone in healthy human subjects: Role of circulating active metabolites. Clinical Pharmacology & Therapeutics, 79(5), 461–479.CrossRef

Laviolette, S. R., Gallegos, R. A., Henriksen, S. J., & van der Kooy, D. (2004). Opiate state controls bi-directional reward signaling via GABAA receptors in the ventral tegmental area. Nature Neuroscience, 7(2), 160–169.PubMedCrossRef

Lee, C. R., McTavish, D., & Sorkin, E. M. (1993). Tramadol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in acute and chronic pain states. Drugs, 46(2), 313–340.PubMed

Lee, T. M., & Pau, C. W. (2002). Impulse control differences between abstinent heroin users and matched controls. Brain Injury, 16(10), 885–889.PubMedCrossRef

Lee, T. M., Zhou, W. H., Luo, X. J., Yuen, K. S., Ruan, X. Z., & Weng, X. C. (2005). Neural activity associated with cognitive regulation in heroin users: A fMRI study. Neuroscience Letters, 382(3), 211–216.PubMedCrossRef

Lenne, M. G., Dietze, P., Rumbold, G. R., Redman, J. R., & Triggs, T. J. (2003). The effects of the opioid pharmacotherapies methadone, LAAM and buprenorphine, alone and in combination with alcohol, on simulated driving. Drug and Alcohol Dependence, 72(3), 271–278.PubMedCrossRef

Levin, J. M., Mendelson, J. H., Holman, B. L., Teoh, S. K., Garada, B., Schwartz, R. B., et al. (1995). Improved regional cerebral blood flow in chronic cocaine polydrug users treated with buprenorphine. Journal of Nuclear Medicine, 36(7), 1211–1215.PubMed

Ling, W., Wesson, D. R., Charuvastra, C., & Klett, C. J. (1996). A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence. Archives of General Psychiatry, 53(5), 401–407.PubMed

London, E., Margolin, R. A., Wong, D. F., Links, J., La France, N. D., Cascella, N. G., et al. (1989). Cerebral glucose utilization in human heroine addicts: case reports from a position emission tomographic study. Research Communications in Substance Abuse, 10, 141–144.

London, E. D., Broussolle, E. P., Links, J. M., Wong, D. F., Cascella, N. G., Dannals, R. F., et al. (1990). Morphine-induced metabolic changes in human brain. Studies with positron emission tomography and [fluorine 18]fluorodeoxyglucose. Archives of General Psychiatry, 47(1), 73–81.PubMed

Lubman, D. I., Peters, L. A., Mogg, K., Bradley, B. P., & Deakin, J. F. (2000). Attentional bias for drug cues in opiate dependence. Psychological Medicine, 30(1), 169–175.PubMedCrossRef

Lyoo, I. K., Pollack, M. H., Silveri, M. M., Ahn, K. H., Diaz, C. I., Hwang, J., et al. (2006). Prefrontal and temporal gray matter density decreases in opiate dependence. Psychopharmacology (Berl), 184(2), 139–144.CrossRef

McLellan, A. T., Luborsky, L., O’Brien, C. P., Barr, H. L., & Evans, F. (1986). Alcohol and drug abuse treatment in three different populations: Is there improvement and is it predictable? American Journal of Drug and Alcohol Abuse, 12(1–2), 101–120.PubMed

McLellan, A. T., Luborsky, L., Woody, G. E., O’Brien, C. P., & Druley, K. A. (1983). Predicting response to alcohol and drug abuse treatments. Role of psychiatric severity. Archives of General Psychiatry, 40(6), 620–625.PubMed

Mintzer, M. Z., Copersino, M. L., & Stitzer, M. L. (2005). Opioid abuse and cognitive performance. Drug and Alcohol Dependence, 78(2), 225–230.PubMedCrossRef

Mintzer, M. Z., Correia, C. J., & Strain, E. C. (2004). A dose-effect study of repeated administration of buprenorphine/naloxone on performance in opioid-dependent volunteers. Drug and Alcohol Dependence, 74(2), 205–209.PubMedCrossRef

Mintzer, M. Z., & Stitzer, M. L. (2002). Cognitive impairment in methadone maintenance patients. Drug and Alcohol Dependence, 67(1), 41–51.PubMedCrossRef

Mitchell, S. H. (1999). Measures of impulsivity in cigarette smokers and non-smokers. Psychopharmacology (Berl), 146(4), 455–464.CrossRef

Nestler, E. J. (1993). Cellular responses to chronic treatment with drugs of abuse. Critical Reviews in Neurobiology, 7(1), 23–39.PubMed

Ng, K. F., Yuen, T. S., & Ng, V. M. (2006). A comparison of postoperative cognitive function and pain relief with fentanyl or tramadol patient-controlled analgesia. Journal of Clinical Anesthesia, 18(3), 205–210.PubMedCrossRef

Nye, H. E., & Nestler, E. J. (1996). Induction of chronic Fos-related antigens in rat brain by chronic morphine administration. Molecular Pharmacology, 49(4), 636–645.PubMed

O’Brien, C. P., Volkow, N., & Li, T. K. (2006). What’s in a word? Addiction versus dependence in DSM-V. American Journal of Psychiatry, 163(5), 764–765.PubMedCrossRef

Ornstein, T. J., Iddon, J. L., Baldacchino, A. M., Sahakian, B. J., London, M., Everitt, B. J., et al. (2000). Profiles of cognitive dysfunction in chronic amphetamine and heroin abusers. Neuropsychopharmacology, 23(2), 113–126.PubMedCrossRef

Pakesch, G., Loimer, N., Grunberger, J., Pfersmann, D., Linzmayer, L., & Mayerhofer, S. (1992). Neuropsychological findings and psychiatric symptoms in HIV-1 infected and noninfected drug users. Psychiatry Research, 41(2), 163–177.PubMedCrossRef

Petry, N. M., Bickel, W. K., & Arnett, M. (1998). Shortened time horizons and insensitivity to future consequences in heroin addicts. Addiction, 93(5), 729–738.PubMedCrossRef

Pickens, R. W., Preston, K. L., Miles, D. R., Gupman, A. E., Johnson, E. O., Newlin, D. B., et al. (2001). Family history influence on drug abuse severity and treatment outcome. Drug and Alcohol Dependence, 61(3), 261–270.PubMedCrossRef

Pirastu, R., Fais, R., Messina, M., Bini, V., Spiga, S., Falconieri, D., et al. (2006). Impaired decision-making in opiate-dependent subjects: Effect of pharmacological therapies. Drug and Alcohol Dependence, 83(2), 163–168.PubMedCrossRef

Preston, K. L., Jasinski, D. R., & Testa, M. (1991). Abuse potential and pharmacological comparison of tramadol and morphine. Drug and Alcohol Dependence, 27(1), 7–17.PubMedCrossRef

Rapeli, P., Kivisaari, R., Autti, T., Kahkonen, S., Puuskari, V., Jokela, O., et al. (2006). Cognitive function during early abstinence from opioid dependence: A comparison to age, gender, and verbal intelligence matched controls. BMC Psychiatry, 6, 9.PubMedCrossRef

Reisine, T. (1995). Opiate receptors. Neuropharmacology, 34(5), 463–472.PubMedCrossRef

Ridenour, T. A., Maldonado-Molina, M., Compton, W. M., Spitznagel, E. L., & Cottler, L. B. (2005). Factors associated with the transition from abuse to dependence among substance abusers: Implications for a measure of addictive liability. Drug and Alcohol Dependence, 80(1), 1–14.PubMedCrossRef

Rodriguez-Llera, M. C., Domingo-Salvany, A., Brugal, M. T., Silva, T. C., Sanchez-Niubo, A., & Torrens, M. (2006). Psychiatric comorbidity in young heroin users. Drug and Alcohol Dependence, 84(1), 48–55.PubMedCrossRef

Rose, J. S., Branchey, M., Buydens-Branchey, L., Stapleton, J. M., Chasten, K., Werrell, A., et al. (1996). Cerebral perfusion in early and late opiate withdrawal: A technetium-99m-HMPAO SPECT study. Psychiatry Research, 67(1), 39–47.PubMedCrossRef

Rotheram-Fuller, E., Shoptaw, S., Berman, S. M., & London, E. D. (2004). Impaired performance in a test of decision-making by opiate-dependent tobacco smokers. Drug and Alcohol Dependence, 73(1), 79–86.PubMedCrossRef

Rounsaville, B. J., Jones, C., Novelly, R. A., & Kleber, H. (1982). Neuropsychological functioning in opiate addicts. Journal of Nervous and Mental Disease, 170(4), 209–216.PubMedCrossRef

Rounsaville, B. J., Kosten, T. R., Weissman, M. M., Prusoff, B., Pauls, D., Anton, S. F., et al. (1991). Psychiatric disorders in relatives of probands with opiate addiction. Archives of General Psychiatry, 48(1), 33–42.PubMed

SAMHSA (2006). Results from the 2005 national survey on drug use and health: National findings. Rockville, MD.

SAMHSA (2007). The DASIS report: Heroin—changes in how it is used: 1995–2005. Rockville, MD: SAMHSA.

Schottenfeld, M. A. (1999). Open capsulorrhaphy with suture anchors for recurrent anterior dislocation of the shoulder. American Journal of Sports Medicine, 27(1), 122.PubMed

Sedo, M. A. (2004a). [‘5 digit test’: a multilinguistic non-reading alternative to the Stroop test]. Revista de Neurologia, 38(9), 824–828.PubMed

Sedo, M. A. (2004b). [SENTREP test: two lists of sentences of equal length to check the attention and the presence of linguistic maturity problems]. Revista de Neurologia, 38(10), 924–927.PubMed

Sell, L. A., Morris, J., Bearn, J., Frackowiak, R. S., Friston, K. J., & Dolan, R. J. (1999). Activation of reward circuitry in human opiate addicts. European Journal of Neuroscience, 11(3), 1042–1048.PubMedCrossRef

Silvasti, M., Svartling, N., Pitkanen, M., & Rosenberg, P. H. (2000). Comparison of intravenous patient-controlled analgesia with tramadol versus morphine after microvascular breast reconstruction. European Journal of Anaesthesiology, 17(7), 448–455.PubMedCrossRef

Silveri, M. M., Pollack, M. H., Diaz, C. I., Nassar, L. E., Mendelson, J. H., Yurgelun-Todd, D. A., et al. (2004). Cerebral phosphorus metabolite and transverse relaxation time abnormalities in heroin-dependent subjects at onset of methadone maintenance treatment. Psychiatry Research, 131(3), 217–226.PubMedCrossRef

Sklair-Tavron, L., Shi, W. X., Lane, S. B., Harris, H. W., Bunney, B. S., & Nestler, E. J. (1996). Chronic morphine induces visible changes in the morphology of mesolimbic dopamine neurons. Proceedings of the National Academy of Sciences of the United States of America, 93(20), 11202–11207.

Stapleton, J. M., Morgan, M. J., Phillips, R. L., Wong, D. F., Yung, B. C., Shaya, E. K., et al. (1995). Cerebral glucose utilization in polysubstance abuse. Neuropsychopharmacology, 13(1), 21–31.PubMedCrossRef

Strain, E. C., Stitzer, M. L., Liebson, I. A., & Bigelow, G. E. (1994). Comparison of buprenorphine and methadone in the treatment of opioid dependence. American Journal of Psychiatry, 151(7), 1025–1030.PubMed

Strain, E. C., Stoller, K., Walsh, S. L., & Bigelow, G. E. (2000). Effects of buprenorphine versus buprenorphine/naloxone tablets in non-dependent opioid abusers. Psychopharmacology (Berl), 148(4), 374–383.CrossRef

Strang, J., & Gurling, H. (1989). Computerized tomography and neuropsychological assessment in long-term high-dose heroin addicts. British Journal of Addiction, 84(9), 1011–1019.PubMedCrossRef

Tassain, V., Attal, N., Fletcher, D., Brasseur, L., Degieux, P., Chauvin, M., et al. (2003). Long term effects of oral sustained release morphine on neuropsychological performance in patients with chronic non-cancer pain. Pain, 104(1–2), 389–400.PubMedCrossRef

Trujillo, K. A. (1995). Effects of noncompetitive N-methyl-D-aspartate receptor antagonists on opiate tolerance and physical dependence. Neuropsychopharmacology, 13(4), 301–307.PubMedCrossRef

Trujillo, K. A. (2000). Are NMDA receptors involved in opiate-induced neural and behavioral plasticity? A review of preclinical studies. Psychopharmacology (Berl), 151(2–3), 121–141.CrossRef

Verdejo, A., Toribio, I., Orozco, C., Puente, K. L., & Perez-Garcia, M. (2005). Neuropsychological functioning in methadone maintenance patients versus abstinent heroin abusers. Drug and Alcohol Dependence, 78(3), 283–288.PubMedCrossRef

Volkow, N. D., Fowler, J. S., Wang, G. J., & Swanson, J. M. (2004). Dopamine in drug abuse and addiction: Results from imaging studies and treatment implications. Molecular Psychiatry, 9(6), 557–569.PubMedCrossRef

Volkow, N. D., Wang, G. J., Fowler, J. S., Logan, J., Hitzemannn, R., Gatley, S. J., et al. (1996). Cocaine uptake is decreased in the brain of detoxified cocaine abusers. Neuropsychopharmacology, 14(3), 159–168.PubMedCrossRef

Warner, L. A., Kessler, R. C., Hughes, M., Anthony, J. C., & Nelson, C. B. (1995). Prevalence and correlates of drug use and dependence in the United States. Results from the National Comorbidity Survey. Archives of General Psychiatry, 52(3), 219–229.PubMed

Wiesbeck, G. A., & Taeschner, K. L. (1991). A cerebral computed tomography study of patients with drug-induced psychoses. European Archives of Psychiatry and Clinical Neuroscience, 241(2), 88–90.PubMedCrossRef

Wise, R. A. (1987). The role of reward pathways in the development of drug dependence. Pharmacology & Therapeutics, 35(1–2), 227–263.CrossRef

Zacny, J. P. (2003). Characterizing the subjective, psychomotor, and physiological effects of a hydrocodone combination product (Hycodan) in non-drug-abusing volunteers. Psychopharmacology (Berl), 165(2), 146–156.

Zacny, J. P. (2005). Profiling the subjective, psychomotor, and physiological effects of tramadol in recreational drug users. Drug and Alcohol Dependence, 80(2), 273–278.PubMedCrossRef

Zacny, J. P., & Gutierrez, S. (2003). Characterizing the subjective, psychomotor, and physiological effects of oral oxycodone in non-drug-abusing volunteers. Psychopharmacology (Berl), 170(3), 242–254.CrossRef

Zacny, J. P., Gutierrez, S., & Bolbolan, S. A. (2005). Profiling the subjective, psychomotor, and physiological effects of a hydrocodone/acetaminophen product in recreational drug users. Drug and Alcohol Dependence, 78(3), 243–252.PubMedCrossRef

Titel: Neuropsychological Consequences of Opiate Use
verfasst von: Staci A. Gruber
Marisa M. Silveri
Deborah A. Yurgelun-Todd
Publikationsdatum: 01.09.2007
Verlag: Springer US
Erschienen in: Neuropsychology Review / Ausgabe 3/2007
Print ISSN: 1040-7308
Elektronische ISSN: 1573-6660
DOI: https://doi.org/10.1007/s11065-007-9041-y

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2007

Acute and Non-acute Effects of Cannabis on Brain Functioning and Neuropsychological Performance

Alcohol and Drug Dependence: Brain Mechanisms and Behavioral Impact

The Role of Cognitive Control in Cocaine Dependence

Motor-Skill Learning in Alzheimer’s Disease: A Review with an Eye to the Clinical Practice

Early Detection of Memory Impairment in Alzheimer’s Disease: A Neurocognitive Perspective on Assessment